Advancements in research on the association between the biological CLOCK and type 2 diabetes.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 12 10 2023
accepted: 15 05 2024
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 14 6 2024
Statut: epublish

Résumé

Due to the Earth's rotation, the natural environment exhibits a light-dark diurnal cycle close to 24 hours. To adapt to this energy intake pattern, organisms have developed a 24-hour rhythmic diurnal cycle over long periods, known as the circadian rhythm, or biological clock. With the gradual advancement of research on the biological clock, it has become increasingly evident that disruptions in the circadian rhythm are closely associated with the occurrence of type 2 diabetes (T2D). To further understand the progress of research on T2D and the biological clock, this paper reviews the correlation between the biological clock and glucose metabolism and analyzes its potential mechanisms. Based on this, we discuss the potential factors contributing to circadian rhythm disruption and their impact on the risk of developing T2D, aiming to explore new possible intervention measures for the prevention and treatment of T2D in the future. Under the light-dark circadian rhythm, in order to adapt to this change, the human body forms an internal biological clock involving a variety of genes, proteins and other molecules. The main mechanism is the transcription-translation feedback loop centered on the CLOCK/BMAL1 heterodimer. The expression of important circadian clock genes that constitute this loop can regulate T2DM-related blood glucose traits such as glucose uptake, fat metabolism, insulin secretion/glucagon secretion and sensitivity in various peripheral tissues and organs. In addition, sleep, light, and dietary factors under circadian rhythms also affect the occurrence of T2DM.

Identifiants

pubmed: 38872971
doi: 10.3389/fendo.2024.1320605
pmc: PMC11169578
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1320605

Informations de copyright

Copyright © 2024 Cheng, Zhong, Tan, Huang, Xijie, Pan, Yang, Huang, Li and Tang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Hui Cheng (H)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.
Institute of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Dayuan Zhong (D)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.

Yimei Tan (Y)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.
Graduate school, Guangzhou University of Chinese Medicine, Foshan, China.

Menghe Huang (M)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.
Graduate school, Guangzhou University of Chinese Medicine, Foshan, China.

Sun Xijie (S)

Institute of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Hong Pan (H)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.
Institute of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Zixian Yang (Z)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.
Institute of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Fangmei Huang (F)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.
Institute of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Feifan Li (F)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.
Institute of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Qizhi Tang (Q)

Nanhai Hospital of Traditional Chinese Medicine, Jinan University, Foshan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH